Madrigal Pharmaceuticals (MDGL) Current Deferred Revenue (2010 - 2011)
Madrigal Pharmaceuticals (MDGL) reported Current Deferred Revenue of $3.3 million for Q3 2011, down 25.7% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Current Deferred Revenue (2010 - 2011) Analysis & Trends
At the end of FY2010, Madrigal Pharmaceuticals posted Current Deferred Revenue of $4.57 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,176.80 Bn | 1,145.39 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 639.81 Bn | 558.34 Bn | 17.26 Bn |
| 3 | AbbVie | 503.28 Bn | 476.39 Bn | 12.70 Bn |
| 4 | Merck | 376.70 Bn | 331.08 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.37 Bn | 242.05 Bn | 12.86 Bn |
| 7 | Amgen | 242.34 Bn | 197.74 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.58 Bn | 167.78 Bn | 6.22 Bn |
| 9 | Pfizer | 172.88 Bn | 119.53 Bn | 10.94 Bn |
| 10 | Madrigal Pharmaceuticals | 13.32 Bn | 9.58 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2011 | 3.30 Mn |
| Jun 30, 2011 | 4.45 Mn |
| Dec 31, 2010 | 4.57 Mn |
API Access
Madrigal Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();